Related Experiment Video
Updated: Jun 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Strategic priorities and barriers to an effective anti-doping programme: views and opinions of European NADO leaders
Fredrik Lauritzen1, Michael Petrou2
1Science and Medicine, Anti-doping Norway, Oslo, Norway.
Abstract:
National Anti-Doping Organizations (NADOs) play significant role in implementing the World Anti-Doping Code, yet little empirical research exists regarding their strategic priorities and perceptions about national and global anti-doping measures. This study explored the views of European NADO leaders on key areas for improving anti-doping programmes, perceived deterrent factors, and operational challenges. An online survey was distributed to 34 NADOs ahead of a 2025 European NADO conference; 32 (91%) NADO leaders responded. Across NADOs of all sizes, increased funding was the most frequently selected priority for improving both global (72%) and national (47%) anti-doping systems. Strengthening intelligence and investigation capacity (63%) and implementing values-based education (50%) were also considered essential for global improvement, while, improving testing effectiveness (41%) and expanding education programmes (31%) were key strategic aims within their own NADO. In contrast, increasing the number of tests or enhancing laboratory analyses were generally not considered a priority. More intensive anti-doping education was viewed as the most effective deterrent to prevent anti-doping rule violations (52%), followed by a higher perceived risk of detection (35%). Regarding risks of contamination, dietary supplements were widely regarded as high-risk for athletes in their country (68%), while environmental contamination was considered minimal risk. Major barriers to achieving strategic goals included insufficient funding (50%), limited human resources (31%), and inadequate political support (28%). These findings provide evidence-based insights into the shared challenges and strategic needs of European NADOs, informing future policy development and capacity building within anti-doping systems.
Related Concept Videos
Antiprotozoal Agents
Drug Control Governance: Regulatory Bodies and Their Impact
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Drug Regulation
International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...